Hon Nick Goiran asks about the catalyst, consultation process, and resolution of concerns related to the Therapeutic Goods (Legislative Instruments) Notice (No. 7) 2025. The answer refers back to Commonwealth TGA consultation.

AnsweredQoN 127Legislative Council
Asked
20 May 2025
Portfolio
Health

QuestionView source ↗

I refer to the Therapeutic Goods (Legislative Instruments) Notice (No. 7) 2025 , and I ask: (a) what was the catalyst for bringing about this notice; (b) who was consulted prior to this notice being finalised; (c) in reference to (b), did any person consulted raise any concerns; (d) if yes to (c), what were these concerns; (e) has the finalised notice addressed these concerns; and (f) if no to (e), why not?

AnswerView source ↗

Answered
24 June 2025
Responded by
Parliamentary Secretary to the Minister for Health
Response time
9 days
(a) The catalyst for this Notice was the making of the Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025, by the Commonwealth, under Therapeutic Goods Legislation.
(b)-(f) Consultation was undertaken by the Commonwealth Therapeutic Goods Administration (TGA) for the instrument to which the Notice applies.
The purpose of, and consultation undertaken in relation to, each instrument is set out in the relevant explanatory statement for each instrument, available on the Federal Register of Legislation.

Explore WA Government Data

Search the full archive in the free dashboard, or query programmatically via API.

Explore more